Bernard Coupal
Direttore/Membro del Consiglio presso CARDIAnove, Inc.
Provenienza dei contatti di primo grado di Bernard Coupal
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.
13
| Private Company | Pharmaceuticals: Major | 13 |
CARDIAnove, Inc.
 CARDIAnove, Inc. Medical SpecialtiesHealth Technology CARDIAnove, Inc. engages in the design and development of medical device technologies for temporary and permanent support of the failing heart to improve the quality of life and prolong life of patients suffering from severe congestive heart failure. The company was founded by Conrad Pelletier and Michel Carrier in 1997 and is headquartered in Montréal, Canada.
6
| Private Company | Medical Specialties | 6 |
Société Innovatech du Grand Montréal
1
| Extinct | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bernard Coupal tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| HEC Montréal | College/University | Undergraduate Degree Graduate Degree | |
Oxfam-Québec
 Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Miscellaneous Commercial Services | Director/Board Member | |
Amadeus International, Inc.
 Amadeus International, Inc. Financial ConglomeratesFinance Amadeus International, Inc. operates as a development stage company. It focuses on the marketing of software solutions, such as enterprise quality resource planning, and enterprise quality & compliance management. The company was founded on December 22, 2004 and is headquartered in Quebec, Canada. | Financial Conglomerates | Director/Board Member | |
Victhom Laboratory, Inc.
 Victhom Laboratory, Inc. Medical SpecialtiesHealth Technology Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada. | Medical Specialties | Director/Board Member | |
| NYMOX PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO | |
| Commerce Équitable Oxfam-québec | Corporate Officer/Principal | ||
Financial Executives International Canada
 Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Ecole Nationale Superieure de Chimie de Toulouse | College/University | Undergraduate Degree | |
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Chief Executive Officer | |
| L’Actualité Médicale, Inc. | Founder | ||
| Ecole de Commerce Européenne Bordeaux et Lyon | College/University | Undergraduate Degree | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Biotechnology | Chief Executive Officer | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Sandoz Ltd.
 Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Pharmaceuticals: Major | Director/Board Member | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Chairman | |
Mipharm SpA
 Mipharm SpA Pharmaceuticals: MajorHealth Technology Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
| IMUNON, INC. | Biotechnology | Chairman | |
Aeon Scientific AG
 Aeon Scientific AG Medical SpecialtiesHealth Technology Aeon Scientific AG engages in the development of medical devices for cardiac interventions. Its product supports electro physiologists during ablation procedures, such as for the treatment of Atrial Fibrillation. The technology is a platform with additional potential in other medical applications such as for gastroenterology, neurosurgery and targeted drug delivery in general. The company was founded by Dominik J. Bell in October 2010 and is headquartered in Zurich, Switzerland. | Medical Specialties | Chairman | |
Boehringer Mannheim Diagnostics Corp.
 Boehringer Mannheim Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX. | Medical Specialties | Chief Executive Officer | |
| Medipress Management, Inc. | Founder | ||
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor | |
| EM Lyon Business School | College/University | Undergraduate Degree | |
| ALTUR INVESTISSEMENT | Investment Managers | Chief Executive Officer | |
| PDL BIOPHARMA, INC. | Biotechnology | Chairman | |
| Gannex LLC | Corporate Officer/Principal | ||
| ASCLETIS PHARMA INC. | Biotechnology | Chief Executive Officer | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| Ascletis BioScience Co., Ltd. | Chief Executive Officer | ||
| Ascletis Pharma China Co., Ltd. | Director/Board Member | ||
| Ascletis Xinnuo Medicine Co., Ltd | Chief Executive Officer | ||
| Soundridge Pharmaceuticals (Hong Kong) Co., Ltd. | Director/Board Member | ||
| Gannex Pharma Co Ltd. | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Canada | 19 |
| Stati Uniti | 10 |
| Francia | 9 |
| Svizzera | 6 |
| Cina | 5 |
Settori
| Health Technology | 24 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 73 |
| Chairman | 37 |
| Corporate Officer/Principal | 25 |
| Chief Executive Officer | 24 |
| President | 23 |
Contatti più connessi
| Insiders | |
|---|---|
| Max E. Link | 28 |
| Chandrakant Panchal | 22 |
| Jinzi Wu | 20 |
| François Lombard | 19 |
| Joseph J. Krivulka | 17 |
| Steven Arless | 13 |
| Stephen G. Sudovar | 12 |
| Philip S. Tabbiner | 9 |
| Frédéric Porte | 9 |
| Monique Létourneau | 7 |
| André Monette | 6 |
| Bertrand Cayrol | 5 |
| Luc Tanguay | 4 |
| Brian Davies | 4 |
| Diane Gosselin | 2 |
- Borsa valori
- Insiders
- Bernard Coupal
- Connessioni Società
